Lauren Pinter-Brown, MD is a clinical professor of medicine in the Division of Hematology/Oncology, Department of Medicine, University of California, Irvine School of Medicine. She is responsible for treating patients, coordinating lymphoma clinical research and for mentoring fellows and junior faculty. She has an extensive background and focus in T-cell lymphomas and concentrates on optimizing treatment for patients diagnosed with lymphomas.
Prior to joining UC Irvine Health in 2016, Dr. Pinter-Brown was a part of the UCLA Ronald Reagan Medical Center and David Geffen School of Medicine where she headed UCLA’s lymphoma program. She was the principal investigator for clinical research protocols for patients with Hodgkin's disease, B-cell lymphomas, CD30+ Anaplastic large-cell lymphoma and T-cell lymphomas.
Dr. Pinter-Brown has been a member of the CLF’s Medical Advisory Board since 2000, and has provided editorial and speaking services. She has been an editorial contributor to the CLF’s Forum and has served as a reviewer for many medical publications, including The American Journal of Hematology, Journal of Clinical Dermatology and Journal of Clinical Oncology. She also lectures extensively on leukemia, T-cell lymphoma and cutaneous T-cell lymphoma.
Dr. Pinter-Brown also serves on the Board of Directors of the United States Cutaneous Lymphoma Consortium and is a member of the American Society of Clinical Oncology, American Society of Hematology and the International Society for Cutaneous Lymphoma, among others. She has held various positions with patient advocacy organizations, including the Lymphoma Research Foundation and Ted Mann Family Resource Center.
This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.